Australia’s first clinical trial of stem cell infusion from cord blood as a possible treatment for cerebral palsy (CP) is commencing in Melbourne. The safety trial, led by the Murdoch Childrens Research Institute (MCRI), will recruit patients nationally and take place at The Royal Children’s Hospital. Expected to take two years, the study is being funded by the Cerebral Palsy Alliance Research Foundation and Cell Care, Australia’s largest private cord blood bank. It is the first step in a promising process that eventually aims to find out whether cord blood infusion is both safe and efficacious for children with the condition. 

To find out more, please visit: and


Join Fulbright Scholar and winner of the University of Sydney Award for Professional Achievement, Professor Iona Novak on Wednesday 24 February, to hear the latest research information and exciting advances on stem cell interventions for neurological conditions, and ideas for supporting families considering stem cell tourism. Read more

A study by the Murdoch Childrens Research Institute has found that improved interventions to reduce brain injury and improve lung function at birth can reduce the severity of cerebral palsy.

The article is one of 13 studies featured in a special Australian CP Register supplement for the prestigious Developmental Medicine and Child Neurology journal.

Read more